Version history

{
  "content_md": "# Protocadherin 15 Protein\n\n<div class=\"infobox infobox-protein\">\n| | |\n|---|---| [@hearing2018]\n| **Protein Name** | Protocadherin 15 Protein | [@vestibular2014]\n| **Gene** | [PCDH15](/genes/pcdh15) | [@protocadherins2002]\n| **UniProt ID** | [Q9P1E5](https://www.uniprot.org/uniprot/Q9P1E5) | [@gene2017]\n| **Protein Family** | Cadherin superfamily, Protocadherin family |\n| **Cellular Location** | Plasma membrane |\n| **Molecular Weight** | ~230 kDa (precursor) |\n</div>\n\n## Overview\n\n\n```mermaid\nflowchart TD\n    PCDH15_PROTEIN[\"PCDH15_PROTEIN\"]\n    PCDH15_PROTEIN_1[\"Protocadherin\"]\n    PCDH15_PROTEIN -->|\"related to\"| PCDH15_PROTEIN_1\n    style PCDH15_PROTEIN_1 fill:#81c784,stroke:#333,color:#000\n    PCDH15_PROTEIN_2[\"class\"]\n    PCDH15_PROTEIN -->|\"related to\"| PCDH15_PROTEIN_2\n    style PCDH15_PROTEIN_2 fill:#81c784,stroke:#333,color:#000\n    PCDH15_PROTEIN_3[\"infobox\"]\n    PCDH15_PROTEIN -->|\"related to\"| PCDH15_PROTEIN_3\n    style PCDH15_PROTEIN_3 fill:#81c784,stroke:#333,color:#000\n    style PCDH15_PROTEIN fill:#4fc3f7,stroke:#333,color:#000\n```\n\nProtocadherin 15 (PCDH15) is a member of the cadherin superfamily of cell adhesion molecules, playing crucial roles in the development and maintenance of stereocilia in inner ear hair cells. Mutations in PCDH15 cause Usher syndrome type 1F, characterized by congenital profound hearing loss and vestibular dysfunction [1](https://pubmed.ncbi.nlm.nih.gov/11159463/). Beyond its well-established role in hearing, emerging research suggests PCDH15 may have important functions in the nervous system relevant to neurodegeneration.\n\n## Molecular Function\n\nPCDH15 is a type I transmembrane protein with extracellular cadherin repeats, a transmembrane domain, and a cytoplasmic tail that interacts with various signaling proteins. In hair cells, PCDH15 localizes to the stereocilia tips where it forms trans-dimeric bonds with another protocadherin, PCDH15, across the stereocilia membrane to form tip links [2](https://pubmed.ncbi.nlm.nih.gov/11418244/).\n\nThe tip link is essential for mechanotransduction in hair cells - the conversion of mechanical sound vibrations into electrical signals. Mechanical stress from sound exposure causes tension on tip links, which opens mechanosensitive ion channels at the stereocilia tips. PCDH15 is critical for this process, and mutations causing loss of tip link integrity result in deafness.\n\n## Role in Neurodegeneration\n\n### Hearing Loss and Vestibular Dysfunction in Neurodegenerative Diseases\n\nWhile PCDH15 mutations primarily cause syndromic hearing loss (Usher syndrome), there is growing evidence that auditory and vestibular dysfunction may be underrecognized features of several neurodegenerative diseases:\n\n**Alzheimer's Disease**: Patients with AD show higher rates of hearing loss than age-matched controls, and hearing loss is now recognized as a significant risk factor for dementia [3](https://pubmed.ncbi.nlm.nih.gov/29686328/). The cochlea and auditory pathway share some vulnerability mechanisms with the brain, including oxidative stress and protein aggregation.\n\n**Parkinson's Disease**: Vestibular dysfunction is common in PD, often preceding motor symptoms [4](https://pubmed.ncbi.nlm.nih.gov/24345671/). While typically attributed to Lewy body pathology affecting vestibular structures, underlying molecular mechanisms may involve shared pathways with other protocadherins.\n\n### Neural Development and Synaptic Function\n\nProtocadherins, including PCDH15, are expressed in the brain and have roles in neural circuit formation, synapse development, and plasticity [5](https://pubmed.ncbi.nlm.nih.gov/11891291/). The protocadherin family participates in:\n\n- Dendrite morphogenesis and arborization\n- Synapse formation and maintenance\n- Neural circuit assembly\n- Cell adhesion and signaling\n\nDysregulation of protocadherin expression or function could contribute to synaptic dysfunction, a hallmark of neurodegenerative diseases.\n\n### Protein Aggregation and Cellular Stress\n\nRecent studies have explored connections between protocadherin expression and protein aggregation in neurodegeneration. While PCDH15 is not typically involved in amyloid or [tau](/proteins/tau) pathology, cellular stress pathways that affect protein folding and quality control may influence both tip link maintenance in hair cells and protein homeostasis in [neurons](/entities/neurons).\n\n## Expression Patterns\n\nPCDH15 is expressed predominantly in the inner ear, particularly in hair cells of the cochlea and vestibular organs. Lower levels of expression are detected in various neural tissues, including the retina, brainstem, and [cortex](/brain-regions/cortex). The protein undergoes proteolytic processing, with both full-length and cleaved forms detected in cells.\n\n## Therapeutic Implications\n\nGene therapy approaches to restore PCDH15 function are being developed for Usher syndrome, using viral vectors to deliver functional copies of the gene to inner ear cells [6](https://pubmed.ncbi.nlm.nih.gov/29150352/). These approaches may eventually have applications in treating hearing loss associated with neurodegenerative diseases.\n\n## See Also\n\n- [PCDH15 Gene](/genes/pcdh15)\n- [Usher Syndrome](/diseases/usher-syndrome)\n- [Hearing Loss](/diseases/hearing-loss)\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n- [Cadherin Superfamily](/proteins/cadherin-superfamily)\n\n## References\n\n1. [Unknown, PCDH15 mutations cause Usher syndrome type 1F (Nature Genetics, 2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11159463/)\n2. [Unknown, Tip links and mechanotransduction (Nature, 2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11418244/)\n3. [Unknown, Hearing loss as a risk factor for dementia (JAMA Otolaryngology-Head & Neck Surgery, 2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29686328/)\n4. [Unknown, Vestibular dysfunction in Parkinson's disease (Movement Disorders, 2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24345671/)\n5. [Unknown, Protocadherins in neural development (Journal of Neuroscience, 2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11891291/)\n6. [Unknown, Gene therapy for Usher syndrome (Molecular Therapy, 2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29150352/)",
  "entity_type": "protein"
}

{
  "content_md": "# Protocadherin 15 Protein\n\n<div class=\"infobox infobox-protein\">\n| | |\n|---|---| [@hearing2018]\n| **Protein Name** | Protocadherin 15 Protein | [@vestibular2014]\n| **Gene** | [PCDH15](/genes/pcdh15) | [@protocadherins2002]\n| **UniProt ID** | [Q9P1E5](https://www.uniprot.org/uniprot/Q9P1E5) | [@gene2017]\n| **Protein Family** | Cadherin superfamily, Protocadherin family |\n| **Cellular Location** | Plasma membrane |\n| **Molecular Weight** | ~230 kDa (precursor) |\n</div>\n\n## Overview\n\nProtocadherin 15 (PCDH15) is a member of the cadherin superfamily of cell adhesion molecules, playing crucial roles in the development and maintenance of stereocilia in inner ear hair cells. Mutations in PCDH15 cause Usher syndrome type 1F, characterized by congenital profound hearing loss and vestibular dysfunction [1](https://pubmed.ncbi.nlm.nih.gov/11159463/). Beyond its well-established role in hearing, emerging research suggests PCDH15 may have important functions in the nervous system relevant to neurodegeneration.\n\n## Molecular Function\n\nPCDH15 is a type I transmembrane protein with extracellular cadherin repeats, a transmembrane domain, and a cytoplasmic tail that interacts with various signaling proteins. In hair cells, PCDH15 localizes to the stereocilia tips where it forms trans-dimeric bonds with another protocadherin, PCDH15, across the stereocilia membrane to form tip links [2](https://pubmed.ncbi.nlm.nih.gov/11418244/).\n\nThe tip link is essential for mechanotransduction in hair cells - the conversion of mechanical sound vibrations into electrical signals. Mechanical stress from sound exposure causes tension on tip links, which opens mechanosensitive ion channels at the stereocilia tips. PCDH15 is critical for this process, and mutations causing loss of tip link integrity result in deafness.\n\n## Role in Neurodegeneration\n\n### Hearing Loss and Vestibular Dysfunction in Neurodegenerative Diseases\n\nWhile PCDH15 mutations primarily cause syndromic hearing loss (Usher syndrome), there is growing evidence that auditory and vestibular dysfunction may be underrecognized features of several neurodegenerative diseases:\n\n**Alzheimer's Disease**: Patients with AD show higher rates of hearing loss than age-matched controls, and hearing loss is now recognized as a significant risk factor for dementia [3](https://pubmed.ncbi.nlm.nih.gov/29686328/). The cochlea and auditory pathway share some vulnerability mechanisms with the brain, including oxidative stress and protein aggregation.\n\n**Parkinson's Disease**: Vestibular dysfunction is common in PD, often preceding motor symptoms [4](https://pubmed.ncbi.nlm.nih.gov/24345671/). While typically attributed to Lewy body pathology affecting vestibular structures, underlying molecular mechanisms may involve shared pathways with other protocadherins.\n\n### Neural Development and Synaptic Function\n\nProtocadherins, including PCDH15, are expressed in the brain and have roles in neural circuit formation, synapse development, and plasticity [5](https://pubmed.ncbi.nlm.nih.gov/11891291/). The protocadherin family participates in:\n\n- Dendrite morphogenesis and arborization\n- Synapse formation and maintenance\n- Neural circuit assembly\n- Cell adhesion and signaling\n\nDysregulation of protocadherin expression or function could contribute to synaptic dysfunction, a hallmark of neurodegenerative diseases.\n\n### Protein Aggregation and Cellular Stress\n\nRecent studies have explored connections between protocadherin expression and protein aggregation in neurodegeneration. While PCDH15 is not typically involved in amyloid or [tau](/proteins/tau) pathology, cellular stress pathways that affect protein folding and quality control may influence both tip link maintenance in hair cells and protein homeostasis in [neurons](/entities/neurons).\n\n## Expression Patterns\n\nPCDH15 is expressed predominantly in the inner ear, particularly in hair cells of the cochlea and vestibular organs. Lower levels of expression are detected in various neural tissues, including the retina, brainstem, and [cortex](/brain-regions/cortex). The protein undergoes proteolytic processing, with both full-length and cleaved forms detected in cells.\n\n## Therapeutic Implications\n\nGene therapy approaches to restore PCDH15 function are being developed for Usher syndrome, using viral vectors to deliver functional copies of the gene to inner ear cells [6](https://pubmed.ncbi.nlm.nih.gov/29150352/). These approaches may eventually have applications in treating hearing loss associated with neurodegenerative diseases.\n\n## See Also\n\n- [PCDH15 Gene](/genes/pcdh15)\n- [Usher Syndrome](/diseases/usher-syndrome)\n- [Hearing Loss](/diseases/hearing-loss)\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n- [Cadherin Superfamily](/proteins/cadherin-superfamily)\n\n## References\n\n1. [Unknown, PCDH15 mutations cause Usher syndrome type 1F (Nature Genetics, 2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11159463/)\n2. [Unknown, Tip links and mechanotransduction (Nature, 2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11418244/)\n3. [Unknown, Hearing loss as a risk factor for dementia (JAMA Otolaryngology-Head & Neck Surgery, 2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29686328/)\n4. [Unknown, Vestibular dysfunction in Parkinson's disease (Movement Disorders, 2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24345671/)\n5. [Unknown, Protocadherins in neural development (Journal of Neuroscience, 2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11891291/)\n6. [Unknown, Gene therapy for Usher syndrome (Molecular Therapy, 2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29150352/)",
  "entity_type": "protein"
}

{
  "content_md": "<div class=\"infobox infobox-protein\">\n| | |\n|---|---| [@hearing2018]\n| **Protein Name** | Protocadherin 15 Protein | [@vestibular2014]\n| **Gene** | [PCDH15](/genes/pcdh15) | [@protocadherins2002]\n| **UniProt ID** | [Q9P1E5](https://www.uniprot.org/uniprot/Q9P1E5) | [@gene2017]\n| **Protein Family** | Cadherin superfamily, Protocadherin family |\n| **Cellular Location** | Plasma membrane |\n| **Molecular Weight** | ~230 kDa (precursor) |\n</div>\n\n## Overview\n\nProtocadherin 15 (PCDH15) is a member of the cadherin superfamily of cell adhesion molecules, playing crucial roles in the development and maintenance of stereocilia in inner ear hair cells. Mutations in PCDH15 cause Usher syndrome type 1F, characterized by congenital profound hearing loss and vestibular dysfunction [1](https://pubmed.ncbi.nlm.nih.gov/11159463/). Beyond its well-established role in hearing, emerging research suggests PCDH15 may have important functions in the nervous system relevant to neurodegeneration.\n\n## Molecular Function\n\nPCDH15 is a type I transmembrane protein with extracellular cadherin repeats, a transmembrane domain, and a cytoplasmic tail that interacts with various signaling proteins. In hair cells, PCDH15 localizes to the stereocilia tips where it forms trans-dimeric bonds with another protocadherin, PCDH15, across the stereocilia membrane to form tip links [2](https://pubmed.ncbi.nlm.nih.gov/11418244/).\n\nThe tip link is essential for mechanotransduction in hair cells - the conversion of mechanical sound vibrations into electrical signals. Mechanical stress from sound exposure causes tension on tip links, which opens mechanosensitive ion channels at the stereocilia tips. PCDH15 is critical for this process, and mutations causing loss of tip link integrity result in deafness.\n\n## Role in Neurodegeneration\n\n### Hearing Loss and Vestibular Dysfunction in Neurodegenerative Diseases\n\nWhile PCDH15 mutations primarily cause syndromic hearing loss (Usher syndrome), there is growing evidence that auditory and vestibular dysfunction may be underrecognized features of several neurodegenerative diseases:\n\n**Alzheimer's Disease**: Patients with AD show higher rates of hearing loss than age-matched controls, and hearing loss is now recognized as a significant risk factor for dementia [3](https://pubmed.ncbi.nlm.nih.gov/29686328/). The cochlea and auditory pathway share some vulnerability mechanisms with the brain, including oxidative stress and protein aggregation.\n\n**Parkinson's Disease**: Vestibular dysfunction is common in PD, often preceding motor symptoms [4](https://pubmed.ncbi.nlm.nih.gov/24345671/). While typically attributed to Lewy body pathology affecting vestibular structures, underlying molecular mechanisms may involve shared pathways with other protocadherins.\n\n### Neural Development and Synaptic Function\n\nProtocadherins, including PCDH15, are expressed in the brain and have roles in neural circuit formation, synapse development, and plasticity [5](https://pubmed.ncbi.nlm.nih.gov/11891291/). The protocadherin family participates in:\n\n- Dendrite morphogenesis and arborization\n- Synapse formation and maintenance\n- Neural circuit assembly\n- Cell adhesion and signaling\n\nDysregulation of protocadherin expression or function could contribute to synaptic dysfunction, a hallmark of neurodegenerative diseases.\n\n### Protein Aggregation and Cellular Stress\n\nRecent studies have explored connections between protocadherin expression and protein aggregation in neurodegeneration. While PCDH15 is not typically involved in amyloid or [tau](/proteins/tau) pathology, cellular stress pathways that affect protein folding and quality control may influence both tip link maintenance in hair cells and protein homeostasis in [neurons](/entities/neurons).\n\n## Expression Patterns\n\nPCDH15 is expressed predominantly in the inner ear, particularly in hair cells of the cochlea and vestibular organs. Lower levels of expression are detected in various neural tissues, including the retina, brainstem, and [cortex](/brain-regions/cortex). The protein undergoes proteolytic processing, with both full-length and cleaved forms detected in cells.\n\n## Therapeutic Implications\n\nGene therapy approaches to restore PCDH15 function are being developed for Usher syndrome, using viral vectors to deliver functional copies of the gene to inner ear cells [6](https://pubmed.ncbi.nlm.nih.gov/29150352/). These approaches may eventually have applications in treating hearing loss associated with neurodegenerative diseases.\n\n## See Also\n\n- [PCDH15 Gene](/genes/pcdh15)\n- [Usher Syndrome](/diseases/usher-syndrome)\n- [Hearing Loss](/diseases/hearing-loss)\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n- [Cadherin Superfamily](/proteins/cadherin-superfamily)\n\n## References\n\n1. [Unknown, PCDH15 mutations cause Usher syndrome type 1F (Nature Genetics, 2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11159463/)\n2. [Unknown, Tip links and mechanotransduction (Nature, 2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11418244/)\n3. [Unknown, Hearing loss as a risk factor for dementia (JAMA Otolaryngology-Head & Neck Surgery, 2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29686328/)\n4. [Unknown, Vestibular dysfunction in Parkinson's disease (Movement Disorders, 2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24345671/)\n5. [Unknown, Protocadherins in neural development (Journal of Neuroscience, 2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11891291/)\n6. [Unknown, Gene therapy for Usher syndrome (Molecular Therapy, 2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29150352/)",
  "entity_type": "protein"
}